The use of ACE inhibitors and ARBs in severe chronic kidney disease: point-counterpoint.
Creamer
Lindsay Marie
LM
Memorial University of Newfoundland, St. John's.
Ryan
Jennifer
J
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D016903:Drug Monitoring; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced; D018579:Patient Selection; D051436:Renal Insufficiency, Chronic / Q000188:drug therapy* / Q000401:mortality; D012307:Risk Factors; D017751:Safety Management; D012720:Severity of Illness Index; D015996:Survival Rate; D016896:Treatment Outcome
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors